All news

Relay Therapeutics executive sells 753 shares to cover RSU taxes

Alpha Vantage · Kalkine Media · · AI-summarised by FinFlash

Relay Therapeutics Chief Corporate Development Officer Peter Rahmer sold 753 common shares at

Read original source

RLAY company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.